Clinical Trials Directory

Trials / Conditions / Non-squamous NSCLC

Non-squamous NSCLC

9 registered clinical trials studyying Non-squamous NSCLC — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingNeo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib
NCT06206850
Jair Bar, M.D., Ph.D.Phase 2
Active Not RecruitingPembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients
NCT05751187
Shanghai Chest HospitalPhase 2
UnknownStudy of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamou
NCT05782426
Jiangsu Cancer Institute & HospitalPhase 2
WithdrawnA Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cance
NCT04466917
AmgenPhase 3
Active Not RecruitingAFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFR
NCT04413201
Michael HoppPhase 4
CompletedPhase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon
NCT04447118
Jiangsu HengRui Medicine Co., Ltd.Phase 3
CompletedAtezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
NCT05261438
Hunan Province Tumor Hospital—
UnknownStudy of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line（ALTER-L020）
NCT03755869
First Affiliated Hospital Xi'an Jiaotong UniversityPhase 4
TerminatedStudy for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negat
NCT02454842
Rain Oncology IncPhase 2